“Efficacy and Safety of Ruxolitinib Plus Extracorporeal Photopheresis in Acute and Chronic Graft Versus Host Disease: A Single Center Experience”. Annals of Medical Research, vol. 28, no. 11, Nov. 2021, pp. 2065-70, http://annalsmedres.org/index.php/aomr/article/view/3977.